Literature DB >> 11389123

Post-antibiotic growth suppression of linezolid against Gram-positive bacteria.

W J Munckhof1, C Giles, J D Turnidge.   

Abstract

The in vitro post-antibiotic effects (PAEs) of eight different concentrations of linezolid against Gram-positive cocci were investigated and the results analysed using the sigmoid E(max) model for mathematically modelling the PAE. Mean maximal linezolid PAEs against strains of Staphylococcus aureus, Staphylococcus epidermidis, Enterococcus faecalis, Enterococcus faecium and Streptococcus pneumoniae were 2.2, 1.8, 2.8, 2.0 and 3.0 h, respectively. Resistance to methicillin (for the staphylococci), vancomycin (for the enterococci) and penicillin (for the pneumococci) had no effect on the duration of the PAE. Results of PAE testing support twice-daily dosing of linezolid in humans.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11389123     DOI: 10.1093/jac/47.6.879

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  5 in total

1.  The Oxazolidinones.

Authors:  Gerald A. Evans
Journal:  Curr Infect Dis Rep       Date:  2002-02       Impact factor: 3.725

2.  In vivo pharmacokinetics/pharmacodynamics of colistin and imipenem in Pseudomonas aeruginosa biofilm infection.

Authors:  Wang Hengzhuang; Hong Wu; Oana Ciofu; Zhijun Song; Niels Høiby
Journal:  Antimicrob Agents Chemother       Date:  2012-02-21       Impact factor: 5.191

3.  Subinhibitory concentrations of linezolid reduce Staphylococcus aureus virulence factor expression.

Authors:  Katussevani Bernardo; Norbert Pakulat; Silke Fleer; Annabelle Schnaith; Olaf Utermöhlen; Oleg Krut; Stefan Müller; Martin Krönke
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

4.  Factorial design and post-antibiotic sub-MIC effects of linezolid combined with fosfomycin against vancomycin-resistant enterococci.

Authors:  Yisong Yan; Guang Yang; Yaowen Li; Jun Mao; Shuaishuai Wang; Na Zhang; Huiping Liu; Xiaohui Huang
Journal:  Ann Transl Med       Date:  2022-02

Review 5.  Antibiotics and ECMO in the Adult Population-Persistent Challenges and Practical Guides.

Authors:  Francisco Gomez; Jesyree Veita; Krzysztof Laudanski
Journal:  Antibiotics (Basel)       Date:  2022-03-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.